Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,504 shares at $38.09 ($93K) on 2016-03-30, disclosed to the SEC on 2016-03-31.
Scheduled sale ($93k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.28 | 625 | $23K | 24.4% |
| 2 | $36.28 | 627 | $23K | 24.4% |
| 3 | $38.09 | 625 | $24K | 25.6% |
| 4 | $38.09 | 627 | $24K | 25.6% |
| Total | $37.19 avg | 2,504 | $93K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |